CPM's Water Rights Litigation Group has conducted a three-year investigation regarding the taking of public water by private corporations. Some of these companies continue to pump massive amounts of water from the public's natural resources, then bottle it and sell it to consumers for astronomical financial gains. The popularity of drinking bottled water instead of soft drinks has created a booming – and very profitable – line of business for beverage companies. In fact, in 2017, bottled water is expected to surpass soft drinks in popularity.[1]

Read More ›
Civil and Criminal Enforcers Target Generic Drug Price-Fixers

Legal scholars have been forecasting that generic drugs will be the next big antitrust price-fixing case, and 2017 seems to be confirming this prediction thus far. In December 2016, the Antitrust Division of the United States Department of Justice (“DOJ”) charged two former executives of Heritage Pharmaceuticals Inc. with price-fixing, bid rigging, and customer allocation of two generic drugs. Shortly thereafter, 20 states filed civil lawsuits against Heritage and its competitors—Mylan NV, Teva Pharmaceuticals, Mayne Pharma Group Ltd., Heritage Pharmaceuticals Inc., Aurobindo Pharma Ltd., and Citron Pharma LLC—for allegedly conspiring to fix the prices of two generic drugs. The two drugs at issue are the delayed-release version of the antibiotic doxycycline hyclate and the diabetes drug glyburide. A total of 40 states have now filed suits.

Read More ›
Topics: Antitrust
Court Upholds Consumers' Claims that Vizio Unlawfully Collects and Uses Private Consumer Data Collected through its Smart TVs in Cutting-Edge Privacy Case

A federal court judge has upheld privacy-related claims related to the collection and sale of consumer viewer data by Vizio. CPM is co-lead counsel in the class action lawsuit, which alleges that the TV maker failed to inform consumers that it is gathering their viewing histories, including what shows they watch, IP addresses, zip codes, product model numbers, hardware and software versions, chipset IDs, region and language settings, and other data.

Read More ›

As drug addiction in the United States continues to gain national attention, the drug addiction rehabilitation industry booms. The Substance Abuse and Mental Health Services Administration estimates the addiction rehabilitation market is about $35 billion each year. While most of the industry provides life saving services for individuals struggling with addiction, some run scams to profit off of addicts and their insurance policies.

Read More ›

Chemical restraints are drugs that are given in nursing homes (skilled nursing facilities) for improper purposes – for example, to make a senior’s behavior more “manageable” and for staff convenience.  Sadly, although against the law – chemical restraints are widely used.  According to professionals who oversee the health and safety of nursing home residents, misuse of chemical restraints can permanently damage the cognition of seniors.  A senior who lived independently and who is subject to chemical restraints at a nursing home may suffer permanent damage.

Read More ›
Topics: Elder Abuse
Mylan Business Practices Harm Consumers, Insurers and the Government

Mylan NV's EpiPen has made headlines recently, and not in a positive way. Outrage grew in August at a jaw dropping 500% price hike for its EpiPen epinephrine auto injectors. The EpiPen is a lifesaving device used to treat severe allergic reactions, or anaphylaxis. The device is essentially a spring loaded syringe that injects a dose of epinephrine into the thigh, even through clothing. 

Read More ›
Protecting Our Seniors (and Taxpayers) – U.S. Department of Justice (DOJ) Indicts Operators of 70 Facility Nursing Home Chain

Fraud in nursing homes is rampant and takes every imaginable form – from the small scale (a staff member who take narcotics from elders to sell on the street) – to the massive (systematic defrauding of the government).  With billions of government dollars flowing through our Nation’s nursing homes it is a hot bed for criminal activity.  Fortunately, whistleblowers and government investigators are able to work together to return funds to the government when there has been fraud or false claims for reimbursement by nursing homes.  

Read More ›
Topics: Elder Abuse

Senior advocates, including elder abuse attorneys have long voiced opposition to the continued use of forced arbitration provisions in nursing home contracts.  In a rule that becomes effective November 28, 2016, the U.S. Government’s Centers for Medicare & Medicaid Services (“CMS”) is prohibiting pre-dispute arbitration clauses in nursing home contracts.  This move is a critical protection for our Nation’s approximately 1.3 million nursing home residents. 

Although the rule will not help elders in assisted living or nursing home residents with contracts that pre-date the November 28, 2016 effective date of the rule, the importance of this move by CMC cannot be understated.  The full text of the final rule, which is over 700 pages in length can be found here.

Our firm, Cotchett, Pitre & McCarthy, LLP represents elders in elder abuse and other types of litigation. We handle a wide range of cases under California’s elder abuse law, including cases involving serious injuries or death – as well as financial fraud.  

Read More ›
Topics: Elder Abuse
Compounded Drug Fraud

Drug compounding is the process by which a pharmacist combines or alters ingredients to make medications tailored to individual patient needs. Common examples include putting medication in liquid form for elderly patients or excluding an allergen. Many people benefit from these services. 

Read More ›

Bedsores – also known as pressure sores, or decubitus ulcers – are extremely painful.  They can lead to death.  A bedsore is an injury to the skin and tissue caused by prolonged pressure on the skin.  To people without medical training the name may seem benign.  They are not.  A Stage 4 bedsore can be an open wound that extends to the bone.

Read More ›
Topics: Elder Abuse

Archives

Jump to Page

By using this site, you agree to our updated Privacy Policy and our Terms of Use.